Cargando…

Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate

BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Nicole, Lawson, Erica, von Scheven, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902884/
https://www.ncbi.nlm.nih.gov/pubmed/29661199
http://dx.doi.org/10.1186/s12969-018-0242-0
_version_ 1783314834080661504
author Ling, Nicole
Lawson, Erica
von Scheven, Emily
author_facet Ling, Nicole
Lawson, Erica
von Scheven, Emily
author_sort Ling, Nicole
collection PubMed
description BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been well-explored. Our objective was to compare risk of adverse pregnancy outcomes in adolescents and young women with SLE to risk among peers without SLE. METHODS: We studied the 2000–2011 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) to estimate the prevalence of adverse pregnancy outcomes in women with SLE aged ≤ 21 years at time of delivery. Outcomes were compared to peers without SLE by using multivariate logistic regression to calculate odds ratios and risk differences. Additionally, differences in length of stay and total charges per hospitalization were described. RESULTS: There were 8,791,391 unique pregnancies, of which 4002 occurred in young women with SLE. After adjustment for age, race, insurance type and quartile of median income based on patient ZIP code individuals with SLE had increased odds of pre-eclampsia/eclampsia (OR 3.2, 95% CI 2.3–4.6), maternal death (OR 80, 95% CI 10–604), preterm birth (OR 2.7, 95% CI 2–3.7), spontaneous abortion (OR 5.1, 95% CI 2.8–9.6), and induced abortion (OR 30, 95% CI 14–63). The increase in risk among women with SLE was greatest for preterm birth (RD 11%, 95% CI 6–16), pre-eclampsia/eclampsia (RD 9%, 95% CI 5–13), and spontaneous abortion (RD 4%, 95% CI 0.9–6). Risk difference for induced abortion was 2% with 95% CI 0.6–4, while the difference in risk for maternal death did not reach statistical significance (RD 0.4, 95% CI -0.4-1). CONCLUSIONS: Adolescents and young women with SLE experience increased risk of adverse, pregnancy-specific outcomes as compared to their peers, including pre-eclampsia/eclampsia, maternal death, preterm birth, spontaneous abortion, and induced abortion. Additionally, length of stay and total charges for hospitalization are increased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12969-018-0242-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5902884
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59028842018-04-23 Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate Ling, Nicole Lawson, Erica von Scheven, Emily Pediatr Rheumatol Online J Research Article BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been well-explored. Our objective was to compare risk of adverse pregnancy outcomes in adolescents and young women with SLE to risk among peers without SLE. METHODS: We studied the 2000–2011 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) to estimate the prevalence of adverse pregnancy outcomes in women with SLE aged ≤ 21 years at time of delivery. Outcomes were compared to peers without SLE by using multivariate logistic regression to calculate odds ratios and risk differences. Additionally, differences in length of stay and total charges per hospitalization were described. RESULTS: There were 8,791,391 unique pregnancies, of which 4002 occurred in young women with SLE. After adjustment for age, race, insurance type and quartile of median income based on patient ZIP code individuals with SLE had increased odds of pre-eclampsia/eclampsia (OR 3.2, 95% CI 2.3–4.6), maternal death (OR 80, 95% CI 10–604), preterm birth (OR 2.7, 95% CI 2–3.7), spontaneous abortion (OR 5.1, 95% CI 2.8–9.6), and induced abortion (OR 30, 95% CI 14–63). The increase in risk among women with SLE was greatest for preterm birth (RD 11%, 95% CI 6–16), pre-eclampsia/eclampsia (RD 9%, 95% CI 5–13), and spontaneous abortion (RD 4%, 95% CI 0.9–6). Risk difference for induced abortion was 2% with 95% CI 0.6–4, while the difference in risk for maternal death did not reach statistical significance (RD 0.4, 95% CI -0.4-1). CONCLUSIONS: Adolescents and young women with SLE experience increased risk of adverse, pregnancy-specific outcomes as compared to their peers, including pre-eclampsia/eclampsia, maternal death, preterm birth, spontaneous abortion, and induced abortion. Additionally, length of stay and total charges for hospitalization are increased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12969-018-0242-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902884/ /pubmed/29661199 http://dx.doi.org/10.1186/s12969-018-0242-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ling, Nicole
Lawson, Erica
von Scheven, Emily
Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title_full Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title_fullStr Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title_full_unstemmed Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title_short Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
title_sort adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902884/
https://www.ncbi.nlm.nih.gov/pubmed/29661199
http://dx.doi.org/10.1186/s12969-018-0242-0
work_keys_str_mv AT lingnicole adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate
AT lawsonerica adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate
AT vonschevenemily adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate